Dr. Steven Hochwald will usher in a new era of nationally recognized cancer care.
MIAMI BEACH, Florida — June 1, 2022 — Mount Sinai Medical Center welcomes Steven Hochwald, MD, MBA, FACS, as the inaugural director of the new Irma and Norman Braman Cancer Center, which is expected to be completed in 2025. Dr. Hochwald will also serve as Chief of Surgical Oncology and holds titles at Columbia University in New York, as part of Mount Sinai’s continued affiliation with the Ivy League institution.
A leading pancreatic and gastrointestinal surgical oncologist and avid researcher, Dr. Hochwald was recruited from the Roswell Park Comprehensive Cancer Center in New York, an NCI-designated institution. Dr. Hochwald’s extensive research focuses on technical advances in minimally invasive upper gastrointestinal surgeries and the development of new targets and agents for the treatment of pancreatic and gastroesophageal malignancies.
Dr. Hochwald brings more than 30 years of clinical experience and research-focused expertise to Mount Sinai’s award-winning cancer program, which holds the only such Ivy League affiliation in South Florida, supported by Columbia University.
“For more than a decade, Mount Sinai’s partnership with Columbia University has provided enhanced expertise and care to the South Florida community,” said Dr. Anil K. Rustgi, Principal of Columbia University. Herbert Irving Comprehensive Cancer Center. “The addition of Dr. Hochwald and his research-based expertise will further enhance the high-quality cancer care that Mount Sinai provides to its patients.
Dr. Hochwald will usher in a new era of patient-centered care as the medical center prepares to build the Braman Cancer Center on the main campus of Mount Sinai in Miami Beach. Dr. Hochwald is focused on expanding oncology services, such as adaptive radiation therapy and robotic surgeries. It will also pave the way for the advancement of technological resources and the development of clinical trials and multidisciplinary clinics for cancer patients.
“We have a unique opportunity to improve the way cancer care is delivered to our community,” said Dr. Hochwald. “Our clinical team of experts, together with the Columbia University team, will create a conduit for further innovation in cancer research, prevention, early detection, therapy and survivorship, through personalized comprehensive care for our patients.”
A graduate of New York University School of Medicine, Dr. Hochwald received postgraduate training in surgical oncology at Memorial Sloan Kettering Cancer Center and completed an oncology fellowship at Memorial Sloan Kettering’s Surgical Metabolism Laboratory. Cancer Centre. He also earned an MBA from the University at Buffalo (SUNY) School of Management and an Executive Diploma in Healthcare Delivery Management from Harvard Business School Executive Education.
While at Roswell Park Cancer Center, Dr. Hochwald created significant volume growth in endoscopy, gastrointestinal and endocrine surgery; provided leadership and direction for clinical growth; and increased efficiency and quality as chief medical officer of all gastrointestinal departments.
Dr. Hochwald’s work has been published in over 200 medical articles, 38 book chapters and guest manuscripts, and over 19 scientific journals. Dr. Hochwald has also conducted many research studies, which aim to help patients with complicated cancers.
“We have deep and extensive expertise in our cancer program,” said Dr. Kfir Ben-David, Chairman of the Department of Surgery. “The addition of Dr. Steven Hochwald further expands our ability to provide comprehensive, research-based care to our patients.
About the Irma and Norman Braman Cancer Center
The Irma and Norman Braman Cancer Center is expected to be completed in the first quarter of 2025. The building will occupy more than 200,000 square feet and will help the medical center’s expert physicians provide state-of-the-art cancer care to all patients. The Braman Cancer Center will provide patients with a wealth of support services to engage individuals and promote a holistic approach to their well-being. These services include nutrition courses, physiotherapy, massages, meditation courses, a dedicated spa, etc.
“The Irma and Norman Braman Cancer Center will meet our community’s growing need for more cancer treatment resources, better access to care and more expertise, providing an unparalleled patient-centered experience,” said Gino R Santorio, President and CEO of Mount Sinai Medical. Center. “Together with Dr. Hochwald, we are focused on continuing to expand our medical workforce, adding new technologies and resources, and expanding access for all.”
Dr. Hochwald will treat patients at the main Mount Sinai campus in Miami Beach. To make an appointment, call 305.674.CARE. For more information on Mount Sinai Medical Center and Mount Sinai Cancer Center, visit msmc.com.
About Mount Sinai Medical Center
Founded in 1949, Mount Sinai Medical Center is South Florida’s largest independent, private, nonprofit teaching hospital. Mount Sinai’s Centers of Excellence combine technology, research and academics to provide innovative and comprehensive care in cardiology, urology, neurology, oncology and orthopedics. One of the few statutory teaching hospitals in the state, Mount Sinai is the hospital of choice for those seeking the level of expertise and care that only a teaching hospital can provide. The medical center’s commitment to quality has earned prestigious recognition, including designation as a comprehensive stroke center and offering some of the best heart attack and heart surgery survival rates in Florida.